Buy This Large Cap Pharma Stock For 16% Potential Upside, Revenues Grew 9.4% YoY, Says ICICI Direct

ICICI Direct in its recent report published on 30th October has assigned a buy call on stock's Dr. Reddy's Laboratories Limited (DRL) for gains of up to 16% in 12 months with a target price of Rs 5,215 per share. Dr

from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/S5ogsVU
via IFTTT